Home » Stocks » Myomo

Myomo Inc. (MYO)

Stock Price: $3.66 USD 0.02 (0.55%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 10.30M
Revenue (ttm) 4.02M
Net Income (ttm) -11.92M
Shares Out 2.81M
EPS (ttm) -13.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $3.66
Previous Close $3.64
Change ($) 0.02
Change (%) 0.55%
Day's Open 3.65
Day's Range 3.58 - 3.69
Day's Volume 116,669
52-Week Range 2.82 - 40.00

More Stats

Market Cap 10.30M
Enterprise Value n/a
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 2.81M
Float 2.55M
EPS (basic) -16.759
EPS (diluted) -13.49
FCF / Share -5.47
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 73,623
Short Ratio 0.40
Short % of Float 2.65%
Beta 1.17
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.57
PB Ratio 0.91
Revenue 4.02M
Operating Income -11.53M
Net Income -11.92M
Free Cash Flow -9.72M
Net Cash 12.37M
Net Cash / Share 4.40
Gross Margin 72.72%
Operating Margin -287.23%
Profit Margin -313.50%
FCF Margin -242.08%
ROA -53.38%
ROE -111.88%
ROIC -7,609.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(132.24% upside)
Current: 3.66
Target: 8.50
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth57.02%56.79%41.29%-
Gross Profit2.921.721.050.82
Operating Income-10.80-10.53-6.55-3.28
Net Income-10.71-10.32-12.10-3.62
Shares Outstanding0.550.410.140.04
Earnings Per Share-19.35-25.18-87.96-123.91
Operating Cash Flow-10.34-9.61-6.15-3.20
Capital Expenditures-0.05-0.13-0.07-
Free Cash Flow-10.39-9.73-6.22-3.20
Cash & Equivalents4.546.6213.010.85
Total Debt2.65--5.45
Net Cash / Debt1.896.6213.01-4.61
Book Value1.826.4312.45-17.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Myomo Inc.
Country United States
Employees 49
CEO Paul R. Gudonis

Stock Information

Ticker Symbol MYO
Stock Exchange NYSE American
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSEAMERICAN: MYO
IPO Date June 12, 2017


Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.